While zinc deficiency may decrease cancer risk through reducing IGF-1, such a deficient state may increase the activity of aromatase (CYP19) [141], an enzyme required for the conversion of androgens, both testosterone and androstenedione [142], to estrogens. Here, IGF1 is linked to cancer.